{
    "domain": "medicine",
    "concept": "approved drug for renal cancer",
    "definition": "A drug approved to treat kidney cancer",
    "selection_criteria": [
        "it is a drug",
        "it has been approved to treat kidney cancer"
    ],
    "referents_source": "https://www.cancer.gov/about-cancer/treatment/drugs/kidney",
    "referents": [
        "Afinitor (Everolimus)",
        "Afinitor Disperz (Everolimus)",
        "Aldesleukin",
        "Alymsys (Bevacizumab)",
        "Avastin (Bevacizumab)",
        "Avelumab",
        "Axitinib",
        "Bavencio (Avelumab)",
        "Belzutifan",
        "Bevacizumab",
        "Cabometyx (Cabozantinib-S-Malate)",
        "Cabozantinib-S-Malate",
        "Everolimus",
        "Fotivda (Tivozanib Hydrochloride)",
        "IL-2 (Aldesleukin)",
        "Inlyta (Axitinib)",
        "Interleukin-2 (Aldesleukin)",
        "Ipilimumab",
        "Keytruda (Pembrolizumab)",
        "Lenvatinib Mesylate",
        "Lenvima (Lenvatinib Mesylate)",
        "Mvasi (Bevacizumab)",
        "Nexavar (Sorafenib Tosylate)",
        "Nivolumab",
        "Nivolumab and Hyaluronidase-nvhy",
        "Opdivo (Nivolumab)",
        "Opdivo Qvantig (Nivolumab and Hyaluronidase-nvhy)",
        "Pazopanib Hydrochloride",
        "Pembrolizumab",
        "Proleukin (Aldesleukin)",
        "Sorafenib Tosylate",
        "Sunitinib Malate",
        "Sutent (Sunitinib Malate)",
        "Temsirolimus",
        "Tivozanib Hydrochloride",
        "Torisel (Temsirolimus)",
        "Votrient (Pazopanib Hydrochloride)",
        "Welireg (Belzutifan)",
        "Yervoy (Ipilimumab)",
        "Zirabev (Bevacizumab)",
        "Cosmegen (Dactinomycin)",
        "Dactinomycin",
        "Doxorubicin Hydrochloride",
        "Vincristine Sulfate"
    ]
}